Cat owners scrolling through pet store shelves keep running into the same three letters lately: CBD. Tinctures, treats, and capsules promise relief for everything from restlessness to stiff joints, and the marketing moves a lot faster than the science behind it.
Cannabidiol, known as CBD, is one of more than 100 compounds found in the Cannabis sativa plant. Unlike THC, it does not produce intoxicating effects. Hemp-derived CBD products sold legally in the United States must contain no more than 0.3% THC by dry weight, a threshold set under federal hemp law. That distinction matters for Holistapet CBD oil for cats specifically, since THC is toxic to felines at doses far lower than what affects humans or even dogs.
How CBD Is Thought to Work in a Cat’s Body
Cats, dogs, and humans all have an endocannabinoid system: a network of CB1 and CB2 receptors spread through the brain, immune tissue, and digestive tract. CBD does not lock onto these receptors directly the way THC does. Current thinking holds that it works indirectly, changing how the body handles its own endocannabinoids along with other signaling molecules such as serotonin.
That mechanism is fairly well mapped in rodents and humans. In cats, the picture is thinner. Feline liver enzymes process certain compounds differently than a dog’s or a person’s does; cats have a reduced capacity for glucuronidation, a metabolic step many drugs rely on for clearance. This partly explains why a dose that behaves one way in a dog cannot be assumed to behave the same way in a cat.
What the Pharmacokinetic Studies Found
A 2019 study published in the journal Animals, led by a Cornell University research team, dosed eight cats and eight dogs with 2 mg/kg of a CBD-rich hemp product twice daily for 12 weeks. Six animals per species were tracked for single-dose pharmacokinetics. The species gap was stark: dogs reached a mean peak serum concentration of 301 ng/mL, while cats topped out around 43 ng/mL. Cats absorbed far less CBD and cleared it from their bloodstream more quickly than dogs did.
Bloodwork over the 12-week period stayed largely within normal ranges, with one notable exception: one cat in the study showed a persistent rise in ALT, a liver enzyme, for the full duration of dosing. That single finding does not prove CBD damages feline livers, but it is the kind of detail a veterinarian would want to know before recommending long-term use.
Later studies have filled in more detail:
- A 2022 Frontiers in Veterinary Science trial using a CBD/CBDA hemp paste recorded an average feline Cmax near 282 ng/mL, with the acidic compound CBDA absorbed noticeably better than CBD alone.
- A 2023 dose-escalation study published in the Journal of Veterinary Pharmacology and Therapeutics gave cats doses ranging from 2.5 mg/kg up to 80 mg/kg. Blood concentrations rose in proportion to dose, and researchers reported no major changes to behavior or standard bloodwork panels across the range tested.
None of these trials set out to prove CBD treats a specific feline illness. They measure how the compound moves through a cat’s system, which is a separate question from whether it changes an actual health outcome.
Where Federal Regulators Stand
The U.S. Food and Drug Administration has not approved any CBD product for use in animals. The one FDA-approved drug containing CBD, Epidiolex, treats rare pediatric seizure disorders in humans and carries no animal indication whatsoever. Under the Federal Food, Drug, and Cosmetic Act, any product marketed to diagnose, treat, cure, or prevent disease in an animal is legally a drug, and drugs require FDA approval before those claims can be made.
That legal gap has produced a steady run of enforcement action. In April 2025, the FDA’s Center for Veterinary Medicine sent warning letters to three companies, including HolistaPet and CBD Dog Health, for marketing CBD products with unsubstantiated claims about treating anxiety, pain, and other conditions in cats and dogs. Months earlier, the agency’s Center for Veterinary Medicine opened a formal request for information asking veterinarians nationwide to share their firsthand observations on cannabis-derived products in animal patients, a comment period that closed in mid-April 2025.
The American Veterinary Medical Association has staked out a similarly cautious position. Because CBD is not FDA-approved for animal use, veterinarians in most states cannot legally prescribe it as a treatment, though many can and do discuss it if an owner brings the subject up during an appointment.
State rules add another layer on top of federal enforcement. A handful of states, including California, Colorado, and Virginia, have passed laws explicitly allowing veterinarians to discuss cannabis products with clients without risking their license, while other states leave the topic in a legal gray zone that makes many vets reluctant to bring it up unprompted. That patchwork means the conversation a cat owner can have with a veterinarian about CBD depends partly on geography, not just on the animal’s health history.
Reading Pharmacokinetic Data the Right Way
| Study | Species tested | Peak concentration (Cmax) | Key takeaway |
|---|---|---|---|
| Deabold et al., 2019 (Animals) | Cats and dogs | 43 ng/mL (cats) vs. 301 ng/mL (dogs) | Cats absorb far less CBD than dogs at the same dose |
| Wang et al., 2022 (Frontiers Vet Sci) | Cats | ~282 ng/mL | CBDA absorbed better than CBD in feline paste formulation |
| Rozental et al., 2023 (J Vet Pharmacol Ther) | Cats | Dose-proportional, 2.5–80 mg/kg range | Higher doses raised blood levels predictably, without major adverse findings |
Numbers like these are useful for researchers designing the next trial. They are less useful on their own for an owner trying to decide on a bottle of oil, since none of the studies above measured whether CBD reduced anxiety, pain, or seizure frequency in cats. A 2025 review in the Journal of Feline Medicine and Surgery summed up where the field currently sits, describing feline cannabinoid absorption as favorable while noting that actual clinical trials on disease outcomes in cats still lag well behind the growing body of canine research.
Common Delivery Formats and Why They Matter
Hemp-derived cat products show up in several forms, and the format changes how predictable the dosing is. Oil tinctures dropped directly into a cat’s mouth or onto food allow for the most precise, adjustable dosing, since the concentration per drop is usually printed on the label. Treats and chews bake CBD into a fixed amount per piece, which is convenient but less flexible if a veterinarian recommends adjusting the amount over time. Capsules sit somewhere in between, offering a set dose without the taste issues that sometimes come with oil.
None of the pharmacokinetic studies referenced above tested every format on the market. The 2019 Cornell trial and the 2023 dose-escalation study both used oil-based products, while the 2022 Frontiers paper tested a paste formulation. Absorption can shift meaningfully depending on carrier oil, whether the cat has eaten recently, and how the product is manufactured, so results from one formulation should not be assumed to transfer directly to another.
Full-spectrum products contain a range of cannabinoids and plant compounds beyond CBD alone, including trace CBDA, which the 2022 feline study found absorbed even better than CBD itself. Broad-spectrum products remove THC while keeping other compounds, and isolate products contain CBD only, with everything else stripped out. Each category carries a different risk profile for trace THC exposure, which matters given how sensitive cats are to that compound compared with dogs or humans.
A Few Practical Notes for Owners
Anyone weighing CBD oil for cats against the current evidence base should keep a short list of realities in mind:
- Dosing studies used controlled, lab-grade CBD; retail tinctures vary widely in potency, purity, and THC contamination.
- A dose considered safe for a dog cannot be assumed safe for a cat given the pharmacokinetic differences documented above.
- Liver values are worth monitoring with a veterinarian if any hemp product is used beyond a few weeks.
- A legitimate product should include a certificate of analysis from an independent lab confirming THC stays under the 0.3% federal threshold.
- Batch testing dates matter as much as the certificate itself; a certificate from a product manufactured two years ago says nothing about the bottle currently on the shelf.
None of this replaces a conversation with a veterinarian familiar with the individual cat’s health history, current medications, and any liver or kidney concerns that might change how the animal processes CBD.
Final Thoughts
The pharmacokinetic research on CBD in cats is real and growing, but it answers how the compound moves through a cat’s body, not whether it treats any specific condition. Anyone considering it should treat the question as open rather than settled and involve a veterinarian before making a change.
